General Questions - Medibeacon

Science

Behind the Science

Fluorescent tracer agents coupled with transdermal detection technology enable physiological monitoring.
More >>

How it Works

Bright fluorescent agents designed not to interact with the body are sensed through the skin.
More >>

R&D Platform

New clinical applications for fluorescent tracer agent-based systems are in development.
More >>

Product Pipeline

Clinical and preclinical studies are underway to advance the use of fluorescence to measure and monitor disease progression.
More >>

Patent Estate

Composition of matter, algorithm, and method patents are a platform for continued innovation.
More >>

Preclinical

Leading academic centers, research institutes, contract research organizations and pharmaceutical companies worldwide rely on MediBeacon technology.
More >>

Clinical

Clinically practical solutions which can reduce the cost of healthcare while improving the standard of care are the goal.
More >>

Focus Areas

Fluorescent agents engineered to not interact with the body have the potential to enable measurement and monitoring of vital organ systems.
More >>

Nephrology

Measurement of GFR is widely accepted as the best indicator of kidney function. A clinically practical and accurate real-time point of care methodology holds promise.
More >>

Gastroenterology

Increased intestinal permeability is implicated in inflammatory bowel disease. Rapid assessment of gut barrier function is a focus.
More >>

Ophthalmology

Fluorescent agent angiography has the potential to aid in diagnosis and monitoring of vasculature leakage seen in Diabetic Retinopathy, Macular Degeneration and Retinal Vasculitis.
More >>

Surgery

Intraoperative identification of ureter or ureteral injury is critical to prevent serious complications. Use of fluorescent agents could potentially aid in surgical visualization.
More >>

In Discovery

Potential medical applications for fluorescent tracer agent-based systems are wide ranging and target important unmet patient needs.
More >>

Company

History

Technology whose development began inside leading medical technology companies is nearing human application today.
More >>

People

Industry leaders including scientists and clinicians are behind fluorescence enabled technology that has the potential to impact global health.
More >>

By the Numbers

Investment in fluorescence-based systems target multiple multi-billion dollar unmet medical needs.
More >>

Quality Commitment

Our approach to quality concentrates on the integrity of processes and preventive measures.
More >>

News/Media

The latest developments are global in scope.
More >>

Publications

MediBeacon

MediBeacon research advances the development of fluorescence for use in medicine.
More >>

Preclinical

Research using MediBeacon preclinical products is featured at scientific meetings worldwide.
More >>

Industry Literature

Understanding disease progression and medical intervention effectiveness is of paramount importance.
More >>

Contact

Get Updates

Stay up to date on the latest developments.
More >>

Investors

Learn about MediBeacon’s US and International investors.
More >>

General Questions

Let us know how we can continue the conversation.
More >>

GENERAL QUESTIONS

Advances in fluorescent technology brought to light.

General Questions

Let us know how we can continue the conversation.

For more information please provide your contact details, an indication of your areas of interest and any questions you may have.

First Name^{( required )}

Last Name^{( required )}

Organization^{( required )}

E-mail^{( required )}

Phone Number^{( required )} -

Area of Interest^{( required )} Preclinical Clinical Both

Let us know if you would like to receive periodic updates.^{( required )} Yes No

Questions

By checking this box, you agree to allow us to store the data from this form and agree to receive further email communication about our products/services and other news. You can change your mind at any time by contacting us or clicking the unsubscribe link on any email. We use Hatchbuck as our sales and marketing software provider. Also, by checking the box, you acknowledge the information you provide will be transferred to Hatchbuck for processing in compliance with their Terms of Service and Privacy Policy I agree^{( required )}

United States
MediBeacon Inc.
425 N. New Ballas Road
Suite 100
St. Louis, MO 63141
P: (314) 269-5808

Germany
MediBeacon GmbH
Cubex41
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
P: +49 (0)621-150283-15

Greater China
(Exclusive Commercial Partner)
Huadong Medicine Co., Ltd
Telephone: 4008-269-985
+86-(0)571-89908581
Zip: 310011
Address: No.866. Moganshan Road, Hangzhou, Zhejiang Province, China
Email: info@eastchinapharm.com

Science How it Works R&D Platform Product Pipeline Patent Estate Preclinical Clinical Focus Areas Nephrology Gastroenterology Ophthalmology Surgery In Discovery

Publications MediBeacon Publications Preclinical Publications Industry Literature Company History People By the Numbers Quality Commitment News/Media Contact Get Updates Investors General Questions

*MediBeacon products are in various stages of clinical development and are not yet approved for human use.

**The Transdermal GFR System (TGFR) is intended to measure Glomerular Filtration Rate (GFR) in patients with impaired or normal renal function. References on this website to measured kidney function and measured renal function refer to the measured GFR.

MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer

MediBeacon expands management team as

MediBeacon approaching completion of Phase

- Read More

COOKIE CONSENT: We use cookies and similar technologies to recognize your repeat visits and preferences, as well as to analyze traffic, among other things. To learn more about cookies, view our Privacy Policy. By clicking “I Accept” on this banner, or using our site, you consent to the use of cookies unless you have disabled them.

Get Access Register

Login Form